Novartis AG vs Toyota Motor Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Toyota Motor Corp trades at $180.4 (market cap $212.22B). The key difference: Novartis AG is the larger of the two by market cap, and Toyota Motor Corp pays the higher dividend (3.51%). Which is the better fit depends on your goals.
| NVS | TM | |
|---|---|---|
Market Cap | $290.25B | $212.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $248.29 |
52-Week Low | $113.50 | $166.50 |
Enterprise Value | $330.27B | $376.42B |
Dividend Yield | 3.17% | 3.51% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →